Mayo H Fujii1, Ashley C Hodges2, Ruby L Russell2, Kristin Roensch3, Bruce Beynnon2, Thomas P Ahern2, Peter Holoch4, Jesse S Moore4, S Elizabeth Ames5, Charles D MacLean2. 1. Department of Surgery, University of Vermont Medical Center, Burlington, VT; University of Vermont Larner College of Medicine, Burlington, VT. Electronic address: mayo.fujii@uvmhealth.org. 2. University of Vermont Larner College of Medicine, Burlington, VT. 3. Department of Orthopaedics, University of Vermont Medical Center, Burlington, VT. 4. Department of Surgery, University of Vermont Medical Center, Burlington, VT; University of Vermont Larner College of Medicine, Burlington, VT. 5. Department of Orthopaedics, University of Vermont Medical Center, Burlington, VT; University of Vermont Larner College of Medicine, Burlington, VT.
Abstract
BACKGROUND: The number of deaths from prescription opioids in the US continues to increase and remains a major public health concern. Opioid-related deaths parallel prescribing trends, and postoperative opioids are a significant source of opioids in the community. Our objective was to identify opioid prescribing and use patterns after surgery to inform evidence-based practices. STUDY DESIGN: Data from a 340-bed academic medical institution and its affiliated outpatient surgical facility included retrospective medical record data and prospective telephone questionnaire and medical record data. Retrospective data included patients discharged after 1 of 19 procedure types, from July 2015 to June 2016 (n = 10,112). Prospective data included a consecutive sample of general and orthopaedic surgery and urology patients undergoing 1 of 13 procedures, from July 2016 to February 2017 (n = 539). Primary outcomes were the quantity of opioid prescribed and used in morphine milligram equivalents (MME), and the proportion of patients receiving instructions on disposal and nonopioid strategies. RESULTS: In the retrospective dataset, 76% of patients received an opioid after surgery, and 87% of prescriptions were prescribed by residents or advanced practice providers. Median prescription size ranged from 0 to 503 MME, with wide interquartile ranges (IQR) for most procedures. In the prospective dataset, there were 359 participants (67% participation rate). Of these, 92% of patients received an opioid and the median proportion used was 27%, or 24 MME (IQR 0 to 96). Only 18% of patients received disposal instructions, while 84% of all patients received instructions on nonopioid strategies. CONCLUSIONS: Median opioid use after surgery was 27% of the total prescribed, and only 18% of patients reported receiving disposal instructions. Significant variability in opioid prescribing and use after surgery warrants investigation into contributing factors.
BACKGROUND: The number of deaths from prescription opioids in the US continues to increase and remains a major public health concern. Opioid-related deaths parallel prescribing trends, and postoperative opioids are a significant source of opioids in the community. Our objective was to identify opioid prescribing and use patterns after surgery to inform evidence-based practices. STUDY DESIGN: Data from a 340-bed academic medical institution and its affiliated outpatient surgical facility included retrospective medical record data and prospective telephone questionnaire and medical record data. Retrospective data included patients discharged after 1 of 19 procedure types, from July 2015 to June 2016 (n = 10,112). Prospective data included a consecutive sample of general and orthopaedic surgery and urology patients undergoing 1 of 13 procedures, from July 2016 to February 2017 (n = 539). Primary outcomes were the quantity of opioid prescribed and used in morphine milligram equivalents (MME), and the proportion of patients receiving instructions on disposal and nonopioid strategies. RESULTS: In the retrospective dataset, 76% of patients received an opioid after surgery, and 87% of prescriptions were prescribed by residents or advanced practice providers. Median prescription size ranged from 0 to 503 MME, with wide interquartile ranges (IQR) for most procedures. In the prospective dataset, there were 359 participants (67% participation rate). Of these, 92% of patients received an opioid and the median proportion used was 27%, or 24 MME (IQR 0 to 96). Only 18% of patients received disposal instructions, while 84% of all patients received instructions on nonopioid strategies. CONCLUSIONS: Median opioid use after surgery was 27% of the total prescribed, and only 18% of patients reported receiving disposal instructions. Significant variability in opioid prescribing and use after surgery warrants investigation into contributing factors.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Charles D MacLean; Mayo Fujii; Thomas P Ahern; Peter Holoch; Ruby Russell; Ashley Hodges; Jesse Moore Journal: Pain Med Date: 2019-06-01 Impact factor: 3.750
Authors: Juhyeun Kim; Andrew John Tabner; Graham David Johnson; Babette A Brumback; Abraham Hartzema Journal: Dig Dis Sci Date: 2019-08-29 Impact factor: 3.199
Authors: Karsten Bartels; Katharine Mahoney; Kristen M Raymond; Shannon K McWilliams; Ana Fernandez-Bustamante; Richard Schulick; Christian J Hopfer; Susan K Mikulich-Gilbertson Journal: Surg Endosc Date: 2019-04-03 Impact factor: 4.584
Authors: Christopher A Tam; Casey A Dauw; Khurshid R Ghani; Vidhya Gunaseelan; Tae Kim; David A Leavitt; Jeremy Raisky; Phyllis L Yan; John M Hollingsworth Journal: Urology Date: 2019-09-16 Impact factor: 2.649
Authors: Elise A Dasinger; Westyn Branch-Elliman; Steven D Pizer; Hassen Abdulkerim; Amy K Rosen; Martin P Charns; Mary T Hawn; Kamal M F Itani; Hillary J Mull Journal: Am J Surg Date: 2019-01-04 Impact factor: 2.565
Authors: Tracy-Ann Moo; Kate R Pawloski; Varadan Sevilimedu; Jillian Charyn; Brett A Simon; Lisa M Sclafani; George Plitas; Andrea V Barrio; Laurie J Kirstein; Kimberly J Van Zee; Monica Morrow Journal: Ann Surg Oncol Date: 2020-07-30 Impact factor: 5.344
Authors: Chad M Brummett; Jackie Evans-Shields; Christina England; Amanda M Kong; Carolyn R Lew; Caroline Henriques; Nicole M Zimmerman; Eric C Sun Journal: J Manag Care Spec Pharm Date: 2021-02-24